ArticleClinical and translational science2021

Population Pharmacokinetic Analysis of the BTK Inhibitor Zanubrutinib in Healthy Volunteers and Patients With B-Cell Malignancies.

Ying C Ou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.